72.11.Z - Research and experimental development on biotechnology
20.14.Z - Manufacture of other organic basic chemicals
20.59.Z - Manufacture of other chemical products not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
47.78.Z - Other retail sale of new goods in specialised stores
71.20 - Technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
2018 | 2019 | ||
---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss) | -3,5 | -6,6 | -88,9 |
EBITDA | -2,6 | -4,9 | -89,5 |
Short time liabilities | 3,6 | 4,2 | 18,3 |
Equity capital | 4,7 | 4,4 | -6,9 |
Operating profit (EBIT) | -3,5 | -6,3 | -83,1 |
Assets | 14,5 | 22,7 | 56,4 |
Net profit (loss) | -3,5 | -6,6 | -88,9 |
Cash | 2,4 | 12,3 | 412,4 |
Net income from sale | 13,5 | 21,5 | 59,4 |
Liabilities and provisions for liabilities | 9,8 | 18,3 | 86,7 |
Working assets | 8,5 | 17,9 | 110,5 |
Depreciation | 0,8 | 1,4 | 63,4 |
% | % | p.p. | |
Profitability of capital | -74,6 | -151,3 | -76,7 |
Equity capital to total assets | 32,4 | 19,3 | -13,1 |
Gross profit margin | -26 | -30,8 | -4,8 |
EBITDA Margin | -19,3 | -22,9 | -3,6 |
Days | Days | Days | |
Short term commitment turnover cycle | 97 | 72 | -25 |
Current financial liquidity indicator | 1.7264776229858398 | 1.239494800567627 | -0,5 |
Net dept to EBITDA | -1.3913882970809937 | 1.5083932876586914 | 2,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane